Chemoinformaics analysis of 5-Methoxycanthin-6-one
Molecular Weight | 250.257 | nRot | 1 |
Heavy Atom Molecular Weight | 240.177 | nRig | 20 |
Exact Molecular Weight | 250.074 | nRing | 4 |
Solubility: LogS | -3.789 | nHRing | 3 |
Solubility: LogP | 2.369 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 3 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 16 |
No. of Oxygen atom | 2 | No. of Arom Bond | 19 |
nHA | 4 | APOL | 35.5219 |
nHD | 0 | BPOL | 15.4861 |
QED | 0.521 |
Synth | 2.296 |
Natural Product Likeliness | 0.064 |
NR-PPAR-gamma | 0.063 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0.002 |
HIA | 0.004 |
CACO-2 | -4.703 |
MDCK | 0.000023 |
BBB | 0.97 |
PPB | 0.931827 |
VDSS | 0.613 |
FU | 0.0282117 |
CYP1A2-inh | 0.984 |
CYP1A2-sub | 0.9 |
CYP2c19-inh | 0.832 |
CYP2c19-sub | 0.64 |
CYP2c9-inh | 0.486 |
CYP2c9-sub | 0.845 |
CYP2d6-inh | 0.194 |
CYP2d6-sub | 0.89 |
CYP3a4-inh | 0.387 |
CYP3a4-sub | 0.42 |
CL | 6.356 |
T12 | 0.555 |
hERG | 0.141 |
Ames | 0.959 |
ROA | 0.064 |
SkinSen | 0.056 |
Carcinogencity | 0.966 |
EI | 0.736 |
Respiratory | 0.731 |
NR-Aromatase | 0.365 |
Antiviral | Yes |
Prediction | 0.692605 |